JMP Securities analyst Silvan Tuerkcan downgrades Intellia Therapeutics (NASDAQ:NTLA) from Market Outperform to Market Perform.
Assessing Ralph Lauren: Insights From 8 Financial Analysts
In the preceding three months, 8 analysts have released ratings for Ralph Lauren (NYSE:RL), presenting a wide array…